Clinical Trials Browser

Phase 2/3 × Cisplatin × Gynecologic × Clear all

NCT06755515 2025-01-01

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Phase 2/3 Enrolling by invitation

Uterine Cervical Neoplasms

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

Phase 2/3 Completed

101 enrolled 13 charts

Carcinoma, Uterine Cervical Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

Phase 2/3 Not yet recruiting

Endometrial Neoplasms

NCT01683864 2018-01-30

HIPECStomach

Phase 2/3 Terminated

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT01999933 2013-12-03

Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer

Phase 2/3 Unknown

Uterine Cervical Neoplasms